Morgan Stanley Icad Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Icad Inc stock. As of the latest transaction made, Morgan Stanley holds 50,100 shares of ICAD stock, worth $193,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,100

Previous 40,105 24.92%

Holding current value

$193,887

Previous $82,000 131.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.66 - $3.99 $16,591 - $39,880	9,995 Added 24.92%	50,100 $190,000
Q1 2025 May 15, 2025	SELL	$1.87 - $3.69 $36,883 - $72,781	-19,724 Reduced 32.97%	40,105 $82,000
Q4 2024 Feb 14, 2025	BUY	$1.39 - $2.4 $22,873 - $39,494	16,456 Added 37.94%	59,829 $109,000
Q3 2024 May 14, 2025	SELL	$1.19 - $1.74 $9,324 - $13,634	-7,836 Reduced 15.3%	43,373 $68,000
Q3 2024 Nov 14, 2024	SELL	$1.19 - $1.74 $9,324 - $13,634	-7,836 Reduced 15.3%	43,373 $68,000
Q2 2024 May 14, 2025	SELL	$1.28 - $1.9 $11,033 - $16,378	-8,620 Reduced 14.41%	51,209 $66,000
Q2 2024 Oct 17, 2024	SELL	$1.28 - $1.9 $8,180 - $12,142	-6,391 Reduced 11.1%	51,209 $66,000
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.9 $8,180 - $12,142	-6,391 Reduced 11.1%	51,209 $66,000
Q1 2024 Oct 17, 2024	BUY	$1.35 - $2.27 $8,627 - $14,507	6,391 Added 12.48%	57,600 $92,000
Q1 2024 Aug 16, 2024	SELL	$1.35 - $2.27 $36,765 - $61,821	-27,234 Reduced 32.1%	57,600 $92,000
Q1 2024 May 15, 2024	SELL	$1.35 - $2.27 $36,765 - $61,821	-27,234 Reduced 32.1%	57,600 $92,000
Q4 2023 Aug 16, 2024	BUY	$1.27 - $2.06 $42,703 - $69,267	33,625 Added 65.66%	84,834 $150,000
Q4 2023 Feb 13, 2024	BUY	$1.27 - $2.06 $11,949 - $19,382	9,409 Added 12.47%	84,834 $150,000
Q3 2023 Nov 15, 2023	BUY	$1.8 - $3.61 $2,201 - $4,415	1,223 Added 1.65%	75,425 $159,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.63 $33,552 - $47,974	29,432 Added 65.74%	74,202 $120,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.84 $2,905 - $6,875	-2,421 Reduced 5.13%	44,770 $55,000
Q4 2022 Feb 14, 2023	SELL	$1.6 - $2.37 $166,768 - $247,025	-104,230 Reduced 68.83%	47,191 $86,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $4.32 $516,507 - $1.09 Million	-253,190 Reduced 62.58%	151,421 $318,000
Q2 2022 Oct 27, 2022	BUY	$3.02 - $4.56 $146,164 - $220,699	48,399 Added 13.59%	404,611 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$3.02 - $4.56 $146,164 - $220,699	48,399 Added 13.59%	404,611 $1.62 Million
Q1 2022 Oct 27, 2022	SELL	$3.92 - $7.48 $189,724 - $362,024	-48,399 Reduced 11.96%	356,212 $1.59 Million
Q1 2022 May 13, 2022	BUY	$3.92 - $7.48 $477,522 - $911,191	121,817 Added 51.97%	356,212 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$6.7 - $11.38 $749,977 - $1.27 Million	111,937 Added 91.41%	234,395 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$10.11 - $17.56 $1.24 Million - $2.15 Million	122,458 New	122,458 $1.32 Million

Others Institutions Holding ICAD

# of Institutions

Shares Held

12.1M

Call Options Held

18K

Put Options Held

20.1K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $98M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account